. 2026 Sep 28;23(9):547–564. doi: 10.26599/1671-5411.2026.09.001

Table 5. Parameter estimates for proportional odds models of the association between predicting variables and RFCA outcomes using LAD, LAEF, LAV_max, LAV_min, or LVEF at different follow-up times.

Measures	Variable	Category	Baseline			1 month			3 months			6 months			12 months
Model	Variable	Category	Est	SE	%	Est	SE	%	Est	SE	%	Est	SE	%	Est	SE	%
LAD	Intercept	2	−6.01	1.91	98.20	−7.01	2.09	99.20	−7.43	2.09	100.00	−7.26	2.05	99.80	−8.19	2.06	100.00
		3	−7.99	1.98	100.00	−9.15	2.18	100.00	−9.63	2.18	100.00	−9.40	2.13	100.00	−10.30	2.15	100.00
	Sex	Male	−1.10	0.44	78.20	−1.11	0.46	75.80	−1.21	0.46	82.60	−1.07	0.46	69.00	−1.12	0.45	77.00
	Age		0.03	0.02	45.60	0.03	0.02	39.40	0.03	0.02	44.40	0.03	0.02	41.00	0.03	0.02	40.40
	AFD		0.17	0.05	98.80	0.18	0.06	97.20	0.14	0.06	72.20	0.18	0.06	93.40	0.16	0.06	88.80
	AFT	1	1.16	0.42	88.40	1.22	0.45	87.60	1.11	0.44	80.60	1.24	0.44	91.00	1.03	0.43	76.60
	MR grade	0	−0.56	0.70	3.80	−0.92	0.77	11.80	−0.50	0.72	2.60	−0.81	0.77	7.80	−0.61	0.71	3.20
		1	−0.09	0.43	0.60	−0.18	0.45	1.20	−0.22	0.44	0.80	−0.07	0.44	0.40	−0.06	0.44	0.40
	Hyperten- sion	Yes	−0.32	0.40	3.40	−0.32	0.42	4.00	−0.57	0.42	15.20	−0.50	0.43	8.80	−0.43	0.41	7.00
	LAD		0.11	0.03	100.00	0.14	0.04	100.00	0.16	0.04	100.00	0.15	0.04	100.00	0.17	0.04	100.00
LAEF	Intercept	2	1.84	1.44	10.60	3.93	1.64	75.60	5.64	1.76	98.40	5.18	1.84	91.00	5.39	1.80	93.80
		3	−0.16	1.43	0.20	1.71	1.60	7.60	3.25	1.69	45.80	2.87	1.79	29.40	3.13	1.75	41.20
	Sex	Male	−0.67	0.43	27.60	−0.58	0.46	14.80	−0.45	0.47	7.80	−0.22	0.48	2.20	−0.18	0.46	1.60
	Age		0.02	0.02	11.40	0.01	0.02	5.00	0.01	0.02	2.00	0.02	0.02	8.40	0.01	0.02	5.00
	AFD		0.17	0.05	98.40	0.16	0.06	89.00	0.14	0.06	66.60	0.15	0.06	70.00	0.17	0.06	92.00
	AFT	1	0.76	0.46	30.40	0.70	0.48	23.20	0.47	0.49	7.20	0.57	0.48	12.60	0.50	0.46	9.20
	MR grade	0	−1.02	0.71	22.80	−0.74	0.74	6.40	−0.54	0.75	4.60	−0.71	0.74	9.60	−0.80	0.72	10.40
		1	−0.29	0.42	1.60	−0.34	0.44	2.00	−0.24	0.46	1.40	−0.42	0.45	4.80	−0.40	0.44	4.80
	Hyperten- sion	Yes	0.11	0.39	0.20	0.13	0.42	0.20	−0.01	0.43	0.40	−0.16	0.43	0.80	0.14	0.41	0.00
	LAEF		−0.06	0.02	100.00	−0.09	0.02	100.00	−0.11	0.02	100.00	−0.11	0.02	100.00	−0.12	0.02	100.00
LAV_max	Intercept	2	−9.17	2.66	99.40	−9.54	2.75	99.60	−11.40	2.83	100.00	−11.00	2.81	100.00	−12.40	2.81	100.00
		3	−11.20	2.73	100.00	−11.60	2.82	100.00	−13.60	2.92	100.00	−13.20	2.90	100.00	−14.60	2.90	100.00
	Sex	Male	−0.86	0.43	51.40	−0.93	0.45	56.60	−0.81	0.46	42.00	−0.56	0.46	14.40	−0.67	0.45	26.20
	Age		0.03	0.02	39.40	0.03	0.02	42.40	0.04	0.02	51.40	0.04	0.02	55.40	0.03	0.02	44.20
	AFD		0.18	0.05	99.00	0.19	0.06	99.40	0.17	0.06	86.40	0.18	0.06	92.00	0.19	0.06	99.40
	AFT	1	0.94	0.44	62.80	1.10	0.46	74.80	0.89	0.46	51.60	1.01	0.45	66.80	0.84	0.43	48.40
	MR grade	0	−0.59	0.70	3.60	−0.47	0.71	2.40	−0.42	0.73	3.20	−0.89	0.73	14.40	−0.70	0.71	7.80
		1	−0.12	0.43	0.40	−0.15	0.45	0.60	−0.14	0.44	0.40	−0.27	0.44	1.00	−0.17	0.43	0.20
	Hyperten- sion	Yes	−0.17	0.39	1.60	−0.23	0.40	2.00	−0.37	0.41	5.60	−0.39	0.42	5.60	−0.18	0.40	1.60
	LAV_max		0.19	0.06	99.60	0.20	0.06	100.00	0.25	0.06	100.00	0.23	0.06	100.00	0.27	0.06	100.00
LAV_min	Intercept	2	−6.97	1.93	99.60	−7.70	1.99	100.00	−8.64	2.04	100.00	−8.40	2.04	100.00	−9.61	2.09	100.00
		3	−9.02	2.01	100.00	−9.87	2.08	100.00	−11.00	2.16	100.00	−10.70	2.15	100.00	−11.90	2.20	100.00
	Sex	Male	−0.75	0.44	37.80	−0.81	0.46	39.80	−0.60	0.47	17.00	−0.37	0.47	5.00	−0.41	0.46	7.00
	Age		0.03	0.02	29.00	0.03	0.02	24.60	0.03	0.02	27.80	0.03	0.02	36.00	0.03	0.02	24.80
	AFD		0.17	0.06	97.80	0.19	0.06	97.80	0.16	0.06	79.80	0.18	0.06	86.60	0.19	0.06	99.00
	AFT	1	0.65	0.46	20.60	0.73	0.48	26.60	0.50	0.48	7.80	0.69	0.47	22.00	0.46	0.46	6.00
	MR grade	0	−0.57	0.71	2.60	−0.34	0.73	1.00	−0.32	0.75	2.20	−0.68	0.75	7.00	−0.54	0.74	4.20
		1	−0.08	0.43	0.40	−0.08	0.45	0.20	−0.10	0.45	0.20	−0.27	0.45	1.20	−0.15	0.44	0.20
	Hyperten- sion	Yes	−0.09	0.39	0.40	−0.15	0.41	1.00	−0.30	0.42	3.20	−0.37	0.43	4.20	−0.09	0.41	0.40
	LAV_min		0.16	0.04	100.00	0.19	0.05	100.00	0.23	0.05	100.00	0.22	0.05	100.00	0.25	0.05	100.00
LVEF	Intercept	2	0.70	1.71	0.40	0.51	1.95	0.20	0.40	2.04	0.00	1.52	2.16	1.00	0.81	2.02	0.00
		3	−1.17	1.71	1.80	−1.59	1.96	1.60	−1.54	2.04	1.60	−0.45	2.16	0.00	−0.99	2.02	0.00
	Sex	Male	−0.96	0.43	65.00	−0.78	0.47	35.20	−0.89	0.46	46.80	−0.92	0.47	49.20	−0.56	0.44	0.00
	Age		0.03	0.02	33.80	0.04	0.02	51.80	0.03	0.02	29.20	0.04	0.02	48.20	0.04	0.02	100.00
	AFD		0.18	0.05	99.20	0.20	0.06	99.60	0.16	0.06	91.20	0.17	0.06	92.00	0.17	0.06	100.00
	AFT	1	1.42	0.42	99.40	1.64	0.46	99.80	1.53	0.45	98.60	1.53	0.45	98.80	1.15	0.43	100.00
	MR grade	0	−1.04	0.67	31.20	−1.50	0.79	48.20	−1.06	0.76	27.00	−1.58	0.86	45.40	−0.89	0.83	0.00
		1	−0.41	0.41	6.00	−0.67	0.44	25.80	−0.47	0.44	7.60	−0.53	0.44	11.60	−0.53	0.42	0.00
	Hyperten- sion	Yes	−0.04	0.38	0.60	−0.19	0.42	1.60	−0.36	0.41	5.60	−0.36	0.43	5.00	0.02	0.41	0.00
	LVEF		−0.03	0.02	9.60	−0.03	0.02	12.40	−0.02	0.02	1.40	−0.04	0.03	24.80	−0.04	0.02	0.00

Table 5. Parameter estimates for proportional odds models of the association between predicting variables and RFCA outcomes using LAD, LAEF, LAVmax, LAVmin, or LVEF at different follow-up times.

Table 5. Parameter estimates for proportional odds models of the association between predicting variables and RFCA outcomes using LAD, LAEF, LAV_max, LAV_min, or LVEF at different follow-up times.